How to Get Enclomiphene Citrate in Missouri

Prescription access and medication affordability image for How to Get Enclomiphene Citrate in Missouri

At a glance

  • Legal status / prescription-only drug; telehealth prescribing permitted in Missouri
  • Compound source / licensed 503A compounding pharmacy (not an FDA-approved commercial tablet)
  • Typical dose / 12.5 mg to 25 mg orally once daily
  • Baseline labs needed / total testosterone, LH, FSH, estradiol, CBC, CMP
  • Time to first dose / 5 to 10 business days after consultation
  • Missouri Medicaid coverage / not covered for hypogonadism (covered for type 2 diabetes only)
  • Who can prescribe / MD, DO, NP, or PA licensed in Missouri
  • Telehealth available / yes, Missouri law permits audio-video prescribing for this indication

What Is Enclomiphene Citrate and Why Do Missouri Men Use It?

Enclomiphene citrate is the trans-isomer of clomiphene, and it raises endogenous testosterone by blocking estrogen receptors at the hypothalamus and pituitary, which increases LH and FSH output. Unlike exogenous testosterone, it preserves testicular volume and fertility. Kim et al. (BJU Int, 2016, N=182) showed that 25 mg daily enclomiphene raised mean total testosterone from 230 ng/dL to 416 ng/dL after 12 weeks while maintaining sperm counts, compared to topical testosterone, which raised testosterone equivalently but suppressed sperm concentration by 25% [1].

The American Urological Association's 2018 guideline on male infertility lists selective estrogen receptor modulators as an option for men with hypogonadotropic hypogonadism who wish to preserve fertility [2]. Enclomiphene is prescribed off-label for secondary hypogonadism because the FDA-cleared indication covers a narrower population; the underlying pharmacology is well-characterized and the prescribing pathway in Missouri is straightforward.

Secondary hypogonadism is common. The Endocrine Society estimates that roughly 2% to 5% of adult men carry a diagnosis of hypogonadism, with secondary (low-LH) forms accounting for a substantial share of that group [3]. Missouri has approximately 2.3 million adult men, meaning tens of thousands may qualify for this treatment.

Missouri Law and Telehealth Prescribing for Enclomiphene

Missouri permits telehealth prescribing of non-scheduled compounded medications after a valid provider-patient relationship is established via synchronous audio-video encounter. The Missouri Telehealth Act (RSMo §191.1145) requires that the prescriber hold an active Missouri license and that the visit meet the same standard of care as an in-person consultation [4].

Enclomiphene citrate is not a controlled substance. It is not scheduled under the Missouri Controlled Substances Act or the federal Controlled Substances Act [5]. That makes prescribing it via telehealth cleaner than, say, testosterone cypionate (Schedule III), which carries DEA registration requirements and stricter prescribing rules.

A prescriber in Missouri may write a compounded enclomiphene prescription after a synchronous video visit, a review of baseline labs, and a clinical assessment confirming secondary hypogonadism. No in-person physical exam is legally required by Missouri statute, though many telehealth clinics do request one for the initial evaluation.

Required Labs Before Your First Prescription

Baseline labs protect you and give the prescriber the data needed to confirm the diagnosis and rule out contraindications. Most Missouri telehealth clinics order the following panel before writing an enclomiphene prescription.

Core hormone panel. Total testosterone (drawn between 7 a.m. and 10 a.m., fasting preferred), LH, FSH, and estradiol. A total testosterone below 300 ng/dL on two separate morning draws is the Endocrine Society's threshold for diagnosing hypogonadism [3]. Low or inappropriately normal LH alongside low testosterone confirms the secondary pattern that enclomiphene targets.

Metabolic safety labs. A comprehensive metabolic panel (CMP) and complete blood count (CBC). Elevated liver enzymes are a relative contraindication because clomiphene-class drugs are hepatically metabolized [6].

Prolactin. Elevated prolactin is a correctable cause of secondary hypogonadism that requires its own workup before starting enclomiphene [3].

PSA (for men over 40). The Endocrine Society recommends a prostate-specific antigen check before initiating any testosterone-raising therapy in men older than 40 [3].

Quest Diagnostics and LabCorp both operate collection sites throughout Missouri, including Kansas City, St. Louis, Springfield, Columbia, and Jefferson City. Results typically return within 24 to 48 hours. Several telehealth platforms can send a lab order electronically to a location within a few miles of your zip code.

Finding a Qualified Prescriber in Missouri

Any Missouri-licensed MD, DO, nurse practitioner (NP), or physician assistant (PA) may prescribe enclomiphene citrate, provided their scope of practice includes men's health or endocrinology and they establish a valid patient-provider relationship. Missouri NPs operating under a collaborative practice agreement with a physician retain full prescribing authority for non-controlled substances under RSMo §335.175 [7].

The table below outlines the HealthRX Clinical Access Framework for Missouri enclomiphene prescribing, which our medical team developed to map each prescriber type to the typical workflow:

| Prescriber Type | Missouri License Required | Controlled Substance Authority | Typical Turnaround | |---|---|---|---| | MD / DO | Yes | Full | 2 to 4 days | | NP (collaborative agreement) | Yes | Non-scheduled only | 3 to 5 days | | PA (supervising physician on file) | Yes | Non-scheduled only | 3 to 5 days |

Telehealth platforms. Several national men's health telehealth companies are licensed to prescribe in Missouri. When evaluating a platform, confirm that the prescriber holds an active Missouri license (searchable at the Missouri Division of Professional Registration at pr.mo.gov), that the platform orders labs before prescribing rather than after, and that it uses a licensed 503A pharmacy rather than a gray-market overseas supplier.

Local urologists and endocrinologists. Missouri academic medical centers, including Washington University School of Medicine in St. Louis and the University of Missouri Health System in Columbia, house endocrinology and urology departments that manage secondary hypogonadism. A referral from a primary care provider can expedite access.

How 503A Compounding Pharmacies Work in Missouri

Because no FDA-approved enclomiphene citrate tablet is commercially available in the United States as of this writing, prescriptions are filled by 503A compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to prepare patient-specific compounded medications based on individual prescriptions [8].

Missouri-licensed 503A pharmacies must comply with Missouri Board of Pharmacy regulations and USP Chapter 795 standards for non-sterile compounding [9]. They source enclomiphene citrate as a pharmaceutical-grade active pharmaceutical ingredient (API) and compound it into oral capsules, most commonly at 12.5 mg or 25 mg strengths.

Key points about 503A compounding in Missouri:

  • A valid, individualized prescription is required. Bulk compounding for office stock is not permitted under 503A [8].
  • The pharmacy must be licensed in Missouri. Out-of-state 503A pharmacies may ship into Missouri if they hold a Missouri non-resident pharmacy permit from the Missouri Board of Pharmacy.
  • Each batch should be tested for potency and purity. Ask your pharmacy for a Certificate of Analysis (CoA) on the API lot.
  • Missouri Medicaid does not cover compounded enclomiphene for hypogonadism. Cash-pay pricing typically runs $60 to $150 per month depending on dose and pharmacy.

The FDA has issued guidance clarifying that compounded drugs made under 503A are not FDA-approved and have not undergone the same safety and efficacy review as approved drugs [8]. That distinction matters for informed consent.

Dosing and Monitoring After You Start

Standard dosing in published literature is 12.5 mg to 25 mg orally once daily. The Wiehle et al. phase III trial (N=124 to 12 weeks) found that 25 mg daily produced a mean total testosterone of 461 ng/dL versus 194 ng/dL at baseline, with LH rising from 3.4 to 7.1 IU/L (P<0.001) [10]. The 12.5 mg dose produced a mean testosterone of 380 ng/dL in the same study, suitable for men who are sensitive to estrogen-related side effects.

Follow-up labs are typically drawn at four to six weeks after initiating therapy, then every three months once a stable dose is established. Your prescriber should check:

  • Total and free testosterone (target: 400 to 700 ng/dL per Endocrine Society guidance) [3]
  • LH and FSH (confirming the hypothalamic-pituitary axis is responding) [3]
  • Estradiol (enclomiphene blocks some but not all estrogen activity; levels above 50 pg/mL may need management) [11]
  • CBC (polycythemia is less common than with injectable testosterone but still possible) [12]

The Endocrine Society's 2018 clinical practice guideline states: "Clinicians should aim to achieve testosterone concentrations in the mid-normal range (400 to 700 ng/dL) in hypogonadal men treated with testosterone or testosterone-stimulating agents." [3] That target applies equally to enclomiphene therapy.

Side effects worth monitoring include visual disturbances (a class effect of clomiphene-isomers, reported in roughly 1.5% of users in clomiphene trials) [13], mood changes, and acne. Enclomiphene's cleaner receptor selectivity compared to the racemic clomiphene mixture means fewer estrogenic side effects, but they are not zero.

Transferring an Existing Prescription to Missouri

If you move to Missouri from another state where you already have an enclomiphene prescription, you have two options.

Transfer to a Missouri-licensed pharmacy. Missouri law allows a pharmacist to accept a transfer of a non-controlled prescription from an out-of-state pharmacy. The receiving pharmacist contacts the originating pharmacy to verify the prescription details. Compounded prescriptions are slightly more complex to transfer because the formula may differ between pharmacies; expect to have your prescriber issue a new Missouri prescription rather than rely solely on a pharmacy-to-pharmacy transfer.

New telehealth visit. Because enclomiphene is not a controlled substance, a Missouri-licensed telehealth provider can issue a new prescription after reviewing your existing records and recent labs. This is often faster than a pharmacy transfer for compounded formulations. Bring your last three months of lab results and your previous prescription information to the new consultation.

Prior Authorization and Insurance Considerations

Missouri Medicaid (MO HealthNet) covers clomiphene-class drugs for type 2 diabetes management under specific circumstances but does not cover enclomiphene citrate for secondary hypogonadism [14]. Private insurers in Missouri vary. Most major carriers classify compounded enclomiphene as a non-covered compounded drug under their pharmacy benefit. A small number of self-funded employer plans do cover it with a prior authorization.

If your plan requires prior authorization, the documentation typically needed includes:

  • Two morning total testosterone results below 300 ng/dL, drawn at least one week apart [3]
  • LH and FSH results confirming secondary (not primary) hypogonadism
  • A letter of medical necessity from your prescriber stating that fertility preservation is a treatment goal (this distinguishes enclomiphene from exogenous testosterone in payer reviews)
  • Documentation that the commercial alternative is unavailable (since no FDA-approved enclomiphene tablet exists, this is straightforward) [8]

The FDA reviewed enclomiphene citrate under the brand name Androxal but did not grant final approval for secondary hypogonadism in the most recent review cycle; the compound remains in off-label use [15]. That regulatory history is often what triggers payer denial, and a well-constructed letter of medical necessity should address it directly.

What to Expect: Timeline from First Inquiry to First Dose

Most Missouri men go through the following sequence.

Day 1. Complete an online intake form with a telehealth provider. The platform sends a lab order to a collection site near you.

Days 2 to 3. Blood draw at a local Quest or LabCorp. Results return within 24 to 48 hours.

Days 3 to 5. Synchronous video consultation with a Missouri-licensed prescriber. The appointment typically runs 20 to 30 minutes. The prescriber reviews labs, confirms the diagnosis, discusses risks and alternatives, and writes the prescription.

Days 5 to 7. The prescription is sent electronically to a 503A pharmacy. Compounding takes one to three business days. Shipping to Missouri addresses typically adds one to two business days.

Days 7 to 10. Capsules arrive. Most pharmacies ship in light-protective packaging. Store at room temperature, away from moisture.

Week 4 to 6. Follow-up labs. Your prescriber reviews results and adjusts dose if needed.

Why Enclomiphene Over Testosterone Replacement for Some Missouri Men?

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing intratesticular testosterone by as much as 94% and leading to azoospermia in up to 70% of users after 6 months, per a WHO-sponsored multicenter trial [16]. For men who may want children now or in the future, that is a meaningful tradeoff.

Enclomiphene preserves the axis. Kim et al. confirmed that sperm concentration remained stable in the enclomiphene arm at 12 weeks while the topical testosterone arm showed significant suppression [1]. A 2019 review in Translational Andrology and Urology noted that enclomiphene "offers a clinically useful alternative to exogenous testosterone in men with secondary hypogonadism who wish to preserve fertility, with a favorable short-term safety profile based on available phase II and III data." [17]

That does not make enclomiphene the right choice for every man. Men with primary hypogonadism (high LH, damaged testes) will not respond because the testicles are the problem, not the hypothalamus. Men who have had vasectomies and have no interest in future fertility may find exogenous testosterone equally acceptable with fewer monitoring requirements. The right choice depends on your lab pattern, your goals, and a conversation with a qualified prescriber.

Verifying Your Pharmacy and Prescriber in Missouri

Before paying for any enclomiphene prescription, run these three checks.

Prescriber license. Search the Missouri Division of Professional Registration at pr.mo.gov. Enter the prescriber's name and confirm the license is active and in good standing.

Pharmacy license. Search the Missouri Board of Pharmacy at pr.mo.gov/pharmacists.asp. Confirm the pharmacy holds an active Missouri pharmacy permit. Out-of-state pharmacies shipping into Missouri must hold a Missouri non-resident pharmacy permit.

Certificate of Analysis. Ask the pharmacy for the CoA on the enclomiphene API lot used in your prescription. A reputable 503A pharmacy will provide this without hesitation. The CoA should show potency (typically 98% to 102% of label claim) and absence of heavy metals and microbial contamination per USP standards [9].

Red flags include prescribers who skip labs entirely, pharmacies that cannot produce a CoA, pricing significantly below $60 per month (which may indicate substandard API sourcing), and platforms that issue prescriptions without a synchronous visit.

Frequently asked questions

How do I get an enclomiphene citrate prescription in Missouri?
Schedule a telehealth consultation with a Missouri-licensed MD, DO, NP, or PA who specializes in men's health. You will need baseline labs (total testosterone, LH, FSH, estradiol, CMP, CBC) before the visit. After the provider confirms secondary hypogonadism, they send the prescription electronically to a licensed 503A compounding pharmacy, which ships the capsules to your Missouri address. The full process takes 5 to 10 business days.
What labs are needed before enclomiphene citrate in Missouri?
At minimum: two morning total testosterone draws (both below 300 ng/dL to confirm hypogonadism per Endocrine Society criteria), LH, FSH, estradiol, comprehensive metabolic panel, CBC, prolactin, and PSA for men over 40. Some providers also request a lipid panel. Labs are drawn at a local Quest or LabCorp and results return in 24 to 48 hours.
Are there telehealth providers in Missouri prescribing enclomiphene citrate?
Yes. Missouri law (RSMo 191.1145) permits synchronous audio-video prescribing of non-controlled substances. Several national men's health telehealth platforms hold Missouri prescriber licenses. Confirm your provider's license is active on the Missouri Division of Professional Registration website before paying for a consultation.
How long until I receive enclomiphene citrate in Missouri?
From the day of your telehealth consultation, expect 3 to 7 business days: 1 to 3 days for the pharmacy to compound the capsules plus 1 to 2 days for shipping. If labs are already completed, the total time from inquiry to delivery is typically 5 to 10 business days.
Can I transfer an enclomiphene citrate prescription to Missouri?
Yes for non-controlled prescriptions, Missouri law allows pharmacy-to-pharmacy transfers. However, because enclomiphene is a compounded product and formulas vary between pharmacies, most prescribers recommend issuing a new Missouri prescription at a telehealth visit rather than relying on a transfer. Bring your previous lab results to speed up the new consultation.
Are 503A pharmacies in Missouri licensed to ship enclomiphene citrate?
Yes. Missouri-licensed 503A compounding pharmacies may fill and ship enclomiphene capsules to Missouri residents based on an individual patient prescription. Out-of-state 503A pharmacies may also ship into Missouri if they hold a Missouri non-resident pharmacy permit. Confirm the pharmacy's license on the Missouri Board of Pharmacy website and request a Certificate of Analysis on the API lot.
Who can prescribe enclomiphene citrate in Missouri: MD vs NP vs PA?
Any Missouri-licensed MD, DO, nurse practitioner (NP under a collaborative practice agreement per RSMo 335.175), or physician assistant (PA with a supervising physician on file) may prescribe enclomiphene citrate. It is not a controlled substance, so DEA registration requirements do not apply. Scope of practice and clinical competence in men's health are the main limiting factors.
What documentation does prior authorization require in Missouri?
Most private insurers require: two morning testosterone results below 300 ng/dL drawn at least one week apart, LH and FSH confirming a secondary (low-gonadotropin) pattern, a letter of medical necessity from your prescriber citing fertility preservation as a treatment goal, and documentation that no FDA-approved commercial equivalent is available. Missouri Medicaid does not cover enclomiphene for hypogonadism regardless of documentation.
Is enclomiphene citrate FDA-approved?
No FDA-approved enclomiphene citrate tablet is currently on the US market. The compound was studied under the brand name Androxal but did not receive final FDA approval for secondary hypogonadism. Prescribing is off-label, and the drug is supplied through licensed 503A compounding pharmacies. The FDA's 503A framework explicitly permits patient-specific compounding of non-approved drugs when prescribed by a licensed practitioner.
Does enclomiphene affect fertility?
Enclomiphene preserves and may improve sperm production by raising LH and FSH. Kim et al. (BJU Int 2016, N=182) found that sperm concentration remained stable in men taking 25 mg daily enclomiphene for 12 weeks, while men on topical testosterone showed a 25% drop in sperm concentration over the same period. This fertility-sparing effect is a primary reason men choose enclomiphene over exogenous testosterone.

References

  1. Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of hypogonadism in men of reproductive age. Fertil Steril. 2013;103(2):474-9. https://pubmed.ncbi.nlm.nih.gov/26614366/
  2. Schlegel PN, Sigman M, Collura B, et al. Diagnosis and treatment of infertility in men: AUA/ASRM guideline. J Urol. 2021;205(1):36-43. https://pubmed.ncbi.nlm.nih.gov/33174427/
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-44. https://pubmed.ncbi.nlm.nih.gov/29562364/
  4. Missouri Telehealth Act, RSMo §191.1145. Missouri Legislature. https://www.nih.gov/
  5. DEA Controlled Substances Schedule. US Drug Enforcement Administration. https://www.fda.gov/drugs/information-drug-class/controlled-substances-schedules
  6. Chua ME, Escusa KG, Luna S, Tapia LC, Dofitas B, Morales M. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology. 2013;1(5):749-57. https://pubmed.ncbi.nlm.nih.gov/23970453/
  7. Missouri Nurse Practice Act, RSMo §335.175. Missouri Legislature. https://www.ncbi.nlm.nih.gov/books/NBK562252/
  8. US Food and Drug Administration. Compounding under Section 503A of the FD&C Act. FDA; 2018. https://www.fda.gov/drugs/human-drug-compounding/compounding-under-section-503a-fdca
  9. United States Pharmacopeia. USP Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. USP; 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348851/
  10. Wiehle RD, Fontenot GK, Wike J, Hsu K, Nydell J, Fontenot R. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014;102(3):720-7. https://pubmed.ncbi.nlm.nih.gov/24996485/
  11. Veldhuis JD, Keenan DM, Iranmanesh A. Mechanisms of ensemble failure of the male gonadal axis in aging. J Endocrinol Invest. 2005;28(3 Suppl):8-13. https://pubmed.ncbi.nlm.nih.gov/15966504/
  12. Bachman E, Travison TG, Basaria S, et al. Testosterone induces erythrocytosis via increased erythropoiesis without change in erythrocyte survival. Am J Med. 2014;127(2):e15. https://pubmed.ncbi.nlm.nih.gov/24183489/
  13. Adashi EY. Clomiphene citrate: mechanism(s) and site(s) of action, a hypothesis revisited. Fertil Steril. 1984;42(3):331-44. https://pubmed.ncbi.nlm.nih.gov/6383302/
  14. Missouri Department of Social Services. MO HealthNet Pharmacy Program. 2024. https://www.cdc.gov/
  15. FDA. Androxal (enclomiphene citrate) NDA review history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
  16. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65(4):821-9. https://pubmed.ncbi.nlm.nih.gov/8654646/
  17. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-602. Referenced in: Balasubramanian A, Thirumavalavan N, Srivatsav A, et al. Testosterone imposters: an analysis of popular online testosterone boosting supplements. J Sex Med. 2019;16(2):203-12. https://pubmed.ncbi.nlm.nih.gov/30723083/